Abbott Says Rival DexCom Breached Patent-License Agreement

December 2, 2021, 3:24 PM UTC

An Abbott Laboratories unit asked a Delaware federal court to clear its FreeStyle Libre products -- the first commercially available continuous glucose monitoring system that avoids fingersticks -- of any infringement claims by DexCom over five patents.

  • Abbott Diabetes Care Inc. sued Wednesday, claiming DexCom breached a confidential July 2014 settlement and license agreement, according to court papers filed concurrently with a sealed complaint in federal court in Wilmington, Delaware
    • Abbott will file public redacted version of complaint within seven days of filing
  • Abbott alleges breach of contract, breach of implied covenant of good faith and fair dealing, and wants ...





Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.